Alerts will be sent to your verified email
Verify Email
COLINZ
|
Colinz Laboratories
|
Starsource Multitrad
|
Norris Medicines
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
4.71 % | -4.44 % | 25.68 % |
|
5yr average Equity Multiplier
|
1.29 | 1.01 | -1.27 |
|
5yr Average Asset Turnover Ratio
|
0.64 | 0.0 | 0.6 |
|
5yr Avg Net Profit Margin
|
5.84 % | 0.0 | -27.67 % |
|
Price to Book
|
1.62 | 11.82 | 0.0 |
|
P/E
|
32.51 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
-11.59 Days | 0.0 | 113.0 Days |
|
Inventory Days
|
56.66 Days | 0.0 | 182.62 Days |
|
Days Receivable
|
42.5 Days | 0.0 | 77.44 Days |
|
Days Payable
|
89.1 Days | 0.0 | 195.35 Days |
|
5yr Average Interest Coverage Ratio
|
11.55 | 670.55 | -1.07 |
|
5yr Avg ROCE
|
6.71 % | -2.98 % | -18.91 % |
|
5yr Avg Operating Profit Margin
|
7.54 % | 0.0 | -2.35 % |
|
5 yr average Debt to Equity
|
0.07 | 0.01 | -1.84 |
|
5yr CAGR Net Profit
|
18.95 % | n/a | -24.21 % |
|
5yr Average Return on Assets
|
3.68 % | -4.07 % | -17.47 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
66.0 % | 27.89 % | 34.0 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -0.04 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Colinz Laboratories
|
Starsource Multitrad
|
Norris Medicines
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|